Pharmacist Perspectives on High-Dose Methotrexate Management and Acute Kidney Injury Risk Mitigation in Patients With Lymphoma: Results From a National Survey

Elizabeth B. King, Mikhaila L. Rice, Huong L. Truong, Kristin C. Cole, Erin F. Barreto, Urshila Durani, Arushi Khurana, Sandra M. Herrmann, Nelson Leung, Thomas E. Witzig, Jason N. Barreto, Department of Pharmacy, Mayo Clinic, Department of Pharmacy, Cleveland Clinic, Department of Quantitative Health Sciences, Mayo Clinic, Department of Pharmacy, Robert D. and Patricia E, Kern Center for the Science of Health Care Delivery, Mayo Clinic, Division of Hematology, Department of Internal Medicine, Mayo Clinic, Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic

Journal of Pharmacy Practice

Published online on February 20, 2026

Abstract

Journal of Pharmacy Practice, Ahead of Print.
Background:A summary of pharmacist-based practices and preferences regarding the prevention and management of high-dose methotrexate (HDMTX) toxicity in patients with lymphoma does not exist. The objective of the study was to describe current practices ...